Art Faulkner

Art Faulkner has over 30 years of work experience in regulatory affairs and CMC within the pharmaceutical industry. Art was the Vice President of Regulatory CMC at TG Therapeutics, Inc., where they were responsible for coordinating and preparing regulatory submissions, as well as drafting responses to CMC related questions from regulatory authorities. Before that, they served as the Senior Director of CMC Regulatory Affairs at Edge Therapeutics, Inc., leading activities such as writing and reviewing CMC sections of regulatory submissions and ensuring compliance with regulations and guidelines. Art Faulkner also held the position of Senior Director of Regulatory Affairs (CMC) at Hurley Consulting Associates Ltd. and Director/Team Leader at Pfizer. Art began their career as a Senior Chemist at Merck.

Art Faulkner earned a Bachelor's degree in Biology, General from the University of Scranton from 1982 to 1986. Art then pursued a Master's degree in Analytical Chemistry at Bucknell University from 1987 to 1990. Later, they attended Rutgers University from 1991 to 1993, although no specific degree was mentioned for this period. It is worth noting that no further information is available beyond these educational experiences.